CEL.L
Celadon Pharmaceuticals Plc, a pharmaceutical company, engages in the research, manufacture, and supply of cannabinoids for use in approved medicines. The company focuses on growing indoor hydroponic THC cannabis for use in medicinal products used to treat chronic pain. It also intends to conduct research into cannabinoids for use in chronic pain, as well as other conditions, such as autism and multiple sclerosis. The company was founded in 2018 and is headquartered in London, the United Kingdom.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2022-03-31
Stock Exchange
LSE
Ticker
CEL.L
According to Celadon Pharmaceuticals Plc’s latest financial reports and current stock price. The company's current ROE is -131.82%. This represents a change of 38.69% compared to the average of -95.05% of the last 4 quarters.
The mean historical ROE of Celadon Pharmaceuticals Plc over the last ten years is -292.32%. The current -131.82% ROE has changed -54.91% with respect to the historical average. Over the past ten years (40 quarters), CEL.L's ROE was at its highest in in the June 2021 quarter at 78.95%. The ROE was at its lowest in in the December 2020 quarter at -758.97%.
Average
-292.32%
Median
-226.09%
Minimum
-1070.13%
Maximum
133.69%
Discovering the peaks and valleys of Celadon Pharmaceuticals Plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 214.24%
Maximum Annual ROE = 133.69%
Minimum Annual Increase = -900.48%
Minimum Annual ROE = -1070.13%
| Year | ROE | Change |
|---|---|---|
| 2023 | -226.09% | -0.34% |
| 2022 | -226.85% | 214.24% |
| 2021 | -72.19% | -93.25% |
| 2020 | -1070.13% | -900.48% |
The current ROE of Celadon Pharmaceuticals Plc (CEL.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-175.05%
5-year avg
-292.32%
10-year avg
-292.32%
Celadon Pharmaceuticals Plc’s ROE is less than MGC Pharmaceuticals Limited (2.66%), greater than Induction Healthcare Group PLC (-14.58%), greater than Advanced Oncotherapy plc (-66.81%), greater than BiVictriX Therapeutics Plc (-67.92%), less than Argent BioPharma Limited (279.26%), greater than Synairgen plc (-51.06%), less than Cambridge Nutritional Sciences plc (14.95%), greater than NetScientific plc (-17.98%), greater than Hellenic Dynamics Plc (-364.21%), greater than Theracryf Plc (-44.95%),
| Company | ROE | Market cap |
|---|---|---|
| 2.66% | N/A | |
| -14.58% | N/A | |
| -66.81% | N/A | |
| -67.92% | N/A | |
| 279.26% | N/A | |
| -51.06% | N/A | |
| 14.95% | N/A | |
| -17.98% | N/A | |
| -364.21% | N/A | |
| -44.95% | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celadon Pharmaceuticals Plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Celadon Pharmaceuticals Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Celadon Pharmaceuticals Plc's ROE?
How is the ROE calculated for Celadon Pharmaceuticals Plc (CEL.L)?
What is the highest ROE for Celadon Pharmaceuticals Plc (CEL.L)?
What is the 3-year average ROE for Celadon Pharmaceuticals Plc (CEL.L)?
What is the 5-year average ROE for Celadon Pharmaceuticals Plc (CEL.L)?
How does the current ROE for Celadon Pharmaceuticals Plc (CEL.L) compare to its historical average?